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Abstract 
 
      Out of 400 samples (340 intestines and 60 cloacal swabs) from cases 
with  signs and lesions of necrotic enteritis, 40 (10%) isolates of 
C.perfringens were obtained(30 isolates from intestines and 10 from cloacal 
swabs) 
      Identification of the isolates was performed using classical 
bacteriological methods which included morphology, Gram stain reactions 
and biochemical tests. 
      Polymerase chain reaction (PCR) technique was used for typing of 
identified C.perfringens isolates in order to determine the presence of α , B , 
B2 , ε , I, and enterotoxin genes. All isolates  carried α toxin gene and this 
confirmed the identity of C.perfringens. Also enterotoxin gene was detected 
in all isolates. 
      All C.perfringens isolates were found to be type A and enterotoxin gene 
positive. 
       Sensitivity tests were conducted on 30 of the isolates using 9 
antimicrobial agents  ampicillin, furazolidone, penicillin, cloxacillin, 
bacitracin, erythromycin, lincomycin, gentamycin and kanamycin. 
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Introduction 
 
       Clostridium perfringens is a Gram-positive anaerobic bacterium that is 
able to form spores. It is wide spread in the environment and is commonly 
found in the intestines of animals and humans, where it is pathogenic in 
certain circumstances. In humans, it can cause gangrene and gastrointestinal 
diseases, where as in other animals, gastrointestinal and enterotoxemic 
diseases occur more frequently. Clostridium.perfringens does not invade 
healthy cells but produces various toxins and enzymes that are responsible 
for the associated lesions and symptoms. The toxins produced depend on the 
Clostridium.perfringens strain involved, and each type of toxin induces a           
specific syndrome (Petit etal., 1999).Classification of 
Clostridium.perfringens into types A, B, C, D or E, is based on major toxin 
production depending on the toxin profile (McClane et al., 2000). 
       Clostridium perfringens plays a significant role in food-borne human 
disease (Mead etal., 1999). Clostridium.perfringens enteritis negatively 
impacts the integrated system of poultry at high levels (Tschirdewahn et al., 
1991). However, its overgrowth in fowl can be considered an imbalance of 
the gut ecosystem at the microbial level resulting in necrotic enteritis 
(Wages and Opergant, 2003). 
       Poultry necrotic enteritis is associated with predisposing factors 
(Elwinger et al., 1992), and is caused by C.perfringens types A or C. The 
organisms replicates readily in the intestinal tract where it produces α toxin 
which are believed to be responsible for the mucosal necrosis (Ficken 
etal.,1997)  and it is a key virulence determinant (Sheedy e tal., 2003). 
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       Molecular typing of the major toxins by a multiplex polymerase chain 
reaction (PCR) is one useful method (Yoo et al., 1997) for grouping of 
C.perfringens isolates into toxin types without inoculation in animals 
(Engstrom et al., 2003). 
       The main objective of the present work was to determine the incidence 
of C.perfringens in the intestines of chickens and to perform toxinotyping of 
C.perfringens by PCR assay for the presence of α-В-В2-ε-ι and enterotoxin 
genes. Also to determine the in vitro susceptibility of C.perfringens to 
different antimicrobials.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3
 
Chapter One 
Literature review 
 
1.1. Genus Clostridium 
 The genus Clostridium includes Gram-positive, spore forming, 
catalase-negative bacilli. More than 100 species of clostridium have been 
described, and many have been recovered from environmental specimens of 
wild and domestic avian species. Pathogenicity of clostridia is mediated 
primarily through potent exotoxin, clostridial diseases may occur as soft 
tissue infections, intoxications and toxico-infections (Miller, 1998). 
 Although some species of Clostridium do grow in the presence of air, 
they can be distinguished from bacillus species by their lack of catalse 
(Smith and Willams, 1984). 
 Members of the genus are found in soil, sewage, marine sediments, 
and the intestinal tracts of human and other animals and in decaying animal 
and plants products. (Cato et al., 1986). Because of the ubiquity of these 
organisms, they find their way into wounds, foods, and feeds and are often 
responsible for serious illness, usually mediated by their toxins (Cato et al., 
1986).  
1.2. Clostridium perfringens: 
 Clostridium.perfringens is the most widely occurring pathogenic 
bacterium (Smith and Williams, 1984). It is readily isolated from the 
intestine of birds and mammals (Hofshagen and Stenwig, 1992). Spores of 
C. perfringens usually are rare or not observed in cultures grown in ordinary 
media, so it must be recognized by its other characteristics (Holdeman et  
al., 1977). A characteristic feature of C. perfringens is the large number of 
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toxins this organism is capable of producing: up to 17 different exotoxins, of 
which some are more commonly produced than others. In addition, some C. 
perfringens also produces an enterotoxin, CPE (Songer, 1996) 
 
 
1.2.1. Basic characterstics: 
 Clostridium. perfringens is a Gram-positive, rod-shaped anaerobe that 
forms oval subterminal spores. It differs from most other clostridia in that 
they are relatively large rods (0.6 – 2.4 X 1.3 – 9.0 µm) encapsulated and 
non motile (Cato, George and Finegold; 1986). The colonies are smooth, 
round, glistening, surrounded by an inner zone of complete haemolysis 
caused by the theta-toxin and an outer zone of incomplete haemolysis caused 
by the α toxin (Quinn et al., 1994). 
 Clostridium.perfringenis is classified as an anaerobe, although the 
bacteria will survive and occasionally grow in the presence of oxygen 
(Quinn et al., 1994). Growth occurs within the temperature range of 12-
50°C, though very slowly below 20°C (Adams and Moss, 1995). 
 Under optimal conditions, 43-47°C, C. perfringens grows extremely 
rapidly, with a generation time of 8-10 min, and growth is accompanied by 
abundant gas production (Bryant and Stevens, 1997). The bacterium requires 
13 essential amino acids for growth (Cato, George and Finegold, 1986). 
1.2.2. Genetic properties: 
 Among the toxigenic clostridial species, C. perfringens is the 
paradigm species for genetic studies, because of its tolerance to oxygen, high 
growth rate, and ability to genetic manipulation (Rood, 1998). In 2002 the 
complete genome of C. perfringens strain 13 was published (Shimizu et al., 
2002). 
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 When C. perfringens genome is compared with the genome of the 
non-pathogenic bacterium, C. acetobutylicum (Nalling et al., 2001), the most 
obvious difference is that virulence-related genes are present in the former, 
but not in the latter. In addition to the known virulence genes, Shimizu found 
many virulence-associated genes in C. perfringens genome (Shimizu et al., 
2002). Five putative haemolysin genes were identified, based on their 
similarity to haemolysins previously described in other bacterial species. 
Two types of Putative fibronectin-binding protein genes sharing similarities 
with genes from listeria monocytogenes (Gilot, Jossin and Content, 2000) 
and Bacillus subtilis (Kunst et al., 1977) were also detected, indicating 
involvement in pathogensis as colonization factors (Shimizu et al., 2002). 
 The genes encoding α-toxin and theta toxin are located on the 
chromosome, many other toxin encoding genes are located on large plasmids 
(Table 1).  The enterotoxin gene (cpe) can be either chromosomal or plasmid 
encoded. In food poisoning isolates, the cpe gene is located on the 
chromosome (Brynestad and Granum, 1999). 
 However, non-food-poisoning human gastro-intestinal disease isolates 
and veterinary isolates carry the cpe gene on large plasmids (Comillot et al., 
1995). 
 Expression of alpha-toxin and theta-toxin is regulated by a two-
component signal transduction system (virR/virs) consisting of two 
components, a sensor histidine kinase, virs, and a response element, VirR. 
Regulation occurs at the transcriptional level and mutations can alter the 
productions of both alpha-toxin and theta-toxin (Rood, 1998). 
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1.2.3. Clostridium perfringens toxins: 
1.2.3.1. Major toxins: 
 Members of the species C. perfringens can be subtyped into five toxin 
types (A, B, C. D and E) based on the production of four major toxins : 
alpha, beta, epsilon and iota (Songer, 1996) C. perfringens is unique not 
only in terms of the number of toxins produced, but also in terms of their 
toxicity and lethal activity. 
 
 
Table (I) 
The most important C. perfringens toxins 
(Modified from Petit, et al 1999) 
 
Toxin Gene Gene location Biological activity 
Alpha toxin Plc Chromosome Cytolytic, haemolytic, demonecrotic, 
lethal 
Beta toxin cpb1 Plasmid Cytolytic, dermonecrotic, lethal 
Epsilon toxin Etx Plasmid Oedema in various organs liver, 
kidney and C.N.S. 
Iota toxin Ia iap/ Plasmid Disruption of cytoskeleton action  
And Ib Ibp  And cell barrier integrity 
Beta2 toxin cpb2 Plasmid Cytolytic, lethal 
Entero toxin Cpe Chromosome 
plasmid 
Cytotoxin, lethal, causes diarrhea by 
leakage of water and ions 
Theta toxin pfoA Chromosome Lyses red blood cells and modulates 
the host inflammatory response 
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1.2.3.1.1. Alpha toxin: 
 In 1941 Mac Forlane and Knight showed that the alpha-toxin of C. 
perfringens possessed phospholipase C. emzymatic properties. Alpha-toxin, 
the main lethal toxin of C. perfringens is a multifunctional phopholipase, 
produced in varying amounts by almost all C. perfringens isolates. It causes 
hydrolysis of membrane phospholipids in different cells, resulting in lysis or 
other forms of cytotoxicity (Songer, 1997; Tiball, 1993). 
 Alpha-toxin is believed to be the major factor responsible for the 
tissue pathology in myonecrosis (gas gangrene) caused by this organism. 
Immunization of guinea pigs with alpha toxin protects them against gas 
gangrene when challenged with C. perfringens and toxin (Kameyama et al., 
1972). 
 Alpha-toxin has been shown to affect myocardial function, causing 
hypotension and brady-cardia, resulting in shock, a common and after fatal 
feature of gas gangrene (Stevens et al., 1988). 
 Recently, three laboratories almost simultaneously reported cloning 
the alpha-toxin gene from C. perfringens. Titball et al., in England (Titball 
et al., 1989) incorporated fragments of the C. perfringens genome into an E. 
coli plasmid and detected organisms carrying the recombinant plasmid 
containing the gene by their lecithinase reaction on egg yolk agar plates. The 
gene coded for a protein that had a molecular mass of 44.5 KDa and 
appeared to be identical to the alpha-toxin produced by the donor strain. Tso 
and Seibel (1989) in the United States cloned the gene by similar methods . 
 Alpha-toxin production of plasmid-bearing organisms was detected by 
the hemolytic reaction on blood agar plates. They found a2-kb fragment 
inserted into the plasmid that contained 1, 197-nucleotide sequence from C. 
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perfringens that coded for the 399-amino-acid peptide with a molecular 
mass of 43 KDa. The peptide had biological activities similar, it not 
identical, to those of the α -toxin of the donor strain. These researchers also 
cloned the gene for C. bijermentans phospholipase c and found it to be 64% 
homologous in coding for sequence with the C. perfringens α -toxin gene. 
The gene product had 1/50 the activity of the native C. perfringens product 
and of the cloned C. perfringens gene product as measured by hemolysis or 
by phosphatidylcho-line hydrolysis (Hatheway, 1990). Okabe et al. in Japan 
also successfully cloned the C. perfringens α toxin gene and have published 
nucleotide and amino acid sequences identical to those of the other two 
studies (Okabe et al., 1989). 
1.2.3.1.2. Beta toxin: 
 Beta-toxin is a major letal toxin produced by both type B and C 
strains of C. perfringens. It is responsible for the lesions of necrotic enteritis 
of pig-bel (Murrell et al., 1966). Lawrence and Cooke (1980) showed that 
beta-toxin of type C organisms will produce necrotic lesions in the small 
intestines of guinea pigs only when protease inhibitor is introduced into the 
gut. The lesions in the guinea pigs were similar to those observed in human 
pig-bel patients. The experimental results supported the following 
hypothesis: that pig-bel occurs because the victims have low protease 
activity in their intestines due to a normally low protein diet and that the low 
level of protease activity is further inhabited by protease inhibitors present in 
sweet potatoes that are consumed in large quantities at the New Guinea 
feasts, along with the pork that serves as the source of the pathogen (Murrell 
et al., 1966). Immunization of gunea pigs with beta-toxin protects them from 
the pig-bel like disease after challenge with either toxin or organism and the 
protease inhibitors (Hatheway, 1990). Beta-toxin can be recovered from 
 9
culture fluid and purified by affinity chromatography on hydrophilic vinyl 
resin (Sakurai and Fujii, 1987).    
 The purified toxin has a molecular mass of 40 KDa and an isoelectric 
PH of 5.6. These properties are similar to those of alpha toxin, and for this 
reason it is difficult to separate the two toxins. Administered I.V. into rats, 
beta-toxin causes a rise in blood pressure and a fall in heart rate. The toxin 
apparently induces the release of catecholamines that are responsible for the 
increased blood pressure (Sakurai et al., 1984 and Sakurai et al., 1981). 
 When injected i.d. into guinea pigs, a minimum doses of 2ng causes 
purple areas of dermonecrosis. The 50% lethal dose for adult mice are 310 
and 4,500 ng/kg i.v. and intraperitoneally respectively (Sakurai and Fujii, 
1987). 
1.2.3.1.3. Beta2 toxin:  
 A novel toxin (B2) has recently been identified from a strain isolated 
from a piglet that died of necrotic enteritis (Petit et al., 1999), entero colitis 
in horses (Garmony et al., 2000), enterotoxemia in calves (Manteca et al., 
2002) and clostridial dysentery in lambs (Miserez et al., 1998). 
 Purified CPB2 was reported to be cytotoxic for chinese hamster ovary 
cells and to induce hemorrhagic necrosis of the intestinal mucosa in a guinea 
pig ligated intestinal loop (Jolivet et al., 1986). In 1997, the gene encoding 
this 28-KDa protein was cloned from C. perfringens type C strain 
(CWC245, and its nucleotide sequence was determined (Gilbert et al., 
1997). Since the deduced amino acid sequence showed no significant 
homology with beta toxin, the respective protein corresponded to a new C. 
perfringens toxin, referred to as CPB2.  
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1.2.3.1.4. Epsilon – toxin: 
 Both type B and D strains of C. perfringens produce epsilon-toxin. It 
is produced as a proto toxin that is activated by proteo lytic enzymes 
produced by the same organism (the Keappa – and lambda-toxin) (Willis 
1969), or it can be activated by adding trypsin to the culture. The prototoxin 
is a protein consisting of 311 amino acids, with a molecular mass of 34.25 
KDa based on sedimentation coefficient (Habeeb, 1975). Activition of the 
prototoxin with trypsin involves breaking of the peptide bond between the 
14th and 15th amino acids from the amino terminus (Lys-14-Ala-15) and 
releasing an activation peptide of 14 residues (Bhown and Habeeb, 1977). 
Epsilon toxin primarily affects the intestine by increasing permeability of the 
gut wall, thus enhancing its own uptake, and acts systematically as a lethal 
toxin (Buxton, 1978). After entering the circulation, it causes swollen 
hyperemic kidneys, edema in the lungs, and excess pericardial fluid 
(McDonel, 1980). The effect of increasing vascular permeability can be 
demonstrated by i.d injection of the toxin, after which the injected site will 
be permeable to circulating Evans blue (Buxton, 1978). An enzyme-linked 
immunosorbent assay for epsilon-toxin has been described and proposed as 
an alternative to mouse lethality and specific antibody protection tests 
(Naylor et al., 1987). 
1.2.3.1.5. Iota toxin: 
 Iota toxin was first described more than four decades ago, it is 
produced by type E only (Bosworth, 1943). Iota toxin is a binary toxin 
which is composed of two independent poly peptide chains called iotaa (Ia) 
and iotab (Ib), which are not associated by either covalent or noncovalent 
bonds (Wilkins et al., (1985). The individual chains possess relatively little 
toxicity, but the combination of chains is very potent (Simpson et al., 1987). 
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 In addition to mouse lethality after i.v. injection, iota-toxin has 
dermonecrotic activity (Bosworth, 1943), at subnecrotizing doses, iota-toxin 
injected intracutaneously increases Vasular permeability (Craig and Miles, 
1961). 
 Iota toxin appears to share certain properities with the botulinum 
binary toxin, inducing the ability to promote the movement of fluids across 
membrane (Craig and Miles, 1961; Jensen and Duncan, 1980; Ohishi, 1983; 
and Simpson, 1982). There are also the obvious similarities that both toxins 
are clostridial in origin and both can be released into the gut of a host that 
has succumbed to an opportunistic infection. These similarities suggest that 
the two toxins should be compared in terms of cellular and molecular action 
(Simpson et al., 1987). 
1.2.3.1.6. Enterotoxin: 
 Clostridium.perfringens enterotoxin was isolated and purified 
(Hauschild and Hilsheimer, 1971) and found to be a protein with a molecular 
mass of 35 KDa and an isoelectric pH of 4.3. The amino acid sequence has 
been determinded (Granum, 1986; Richardson and Granum, 1985). The 
toxin consists of one peptide of 309 amino acids with a molecular weight of 
34.262. The peptide has one free sulfhydryl group. The activity of the 
enterotoxin is enhanced three fold by treatment with trypsin (Granum et al., 
1981). Trypsin cleaves at two sites, each involving a lysine residue, cleaving 
15 or an additional 10 amino acids from the amino-terminal end of the toxin 
(Richardson and Granum, 1983). 
 The mechanism of action of the enterotoxin seems to involve direct 
binding of the toxin receptors on the surface of intestinal epithelial cells 
(Hatheway, 1990) Wnek and McClane, 1983 isolated a 50-KDa protein from 
rabbit intestinal brush border membranes that specifically inhibited 
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cytotoxicity for vero cells. This molecule may be the specific receptor for 
the enterotoxin. Binding is followed by insertion of the entire molecule into 
cell membrane, but no internalization into the cell (McClane et al., 1988). A 
sudden change of ion fluxes occurs, affecting cellular metabolism and 
macromolecular synthesis. As intracellular calcium ion levels increase, 
morphological damage occurs, resulting in greatly altered membrane 
permeability and loss of cellular fluid and ions and moderate-sized 
molecules up to 3.5 KDa (McClane et al., 1988). Under some conditions a 
loss of protein molecules may occur, but this may reflect cell death 
(McClane et al., 1988). Based on rabbit studies, the enterotoxin is most 
active in the ileum moderately active in the jejunum, and essentially inactive 
in the duodenum (McDonel, 1980). Entero toxin has been studied almost 
exclusively in type A strains. It has been established that type C and D 
strains also can produce enterotoxin (McDonel, et al 1980). 
1.2.3.2. Minor Toxins: 
 At least some strains produce toxins of all types eg: theta, Kappa, mu, 
nu and neuraminidase. Delta-toxin is a hemolysin produced by type B and C 
strains, but not by type A, D and E strains. Lambda has not been detected in 
type A and C strains. It is a proteinase that digests gelatin, hemoglobin, and 
casein to some extent, but not collagen (Smith and Williams, 1984). Strains 
of any toxin type may be encountered which fail to produce one or more of 
the indicated minor toxins. The minor toxins have been of primary interest in 
the early attempts at classifying members of the species. Kappa-toxin 
(Collagenase) mu-toxin (hyaluronidase), and lambda-toxin (protease) appear 
to play roles in pathogenesis because of their ability to break down host 
tissues Gamma-and eta-toxin have been proposed to account for 
discrepancies in neutralizing results obtained with specific antisera, but 
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specific active substances related to those supposed entities have not yet 
been isolated (McDonel, 1980). 
1.2.3.2.1. Delta Toxin: 
 Delta-toxin has been recovered from C. perfringens type C and 
purified (Alouf and Jolivet, 1981; Tixier and Alouf, 1976). It has a 
molecular mass of 42 KDa and an isoelectric PH of 9%. It has high 
hemolytic activity for erythrocytes from sheep, goats and pigs but is 
relatively inactive against those from humans, horses, rabbits, mice and 
other mammals. The activity is inhibited by gangliosides (especially GM2), 
but not by other lipid compounds such as sphingomyelin, lecithin, or 
cholesterol (Hatheway, 1990). 
1.2.3.2.2. Theta toxin: 
 Theta-toxin, also known as perfringolysin O, is responsible for the 
clear zone of hemolysis produced by at least some strains of all toxin types 
(McDonel, 1980; Smith and Williams, 1984). It is an oxygen-labile, 
thiolactivated cytolysin, similar but not identical to some hemolysins 
produced by other species (Streptococcus pyogenes, Streptococcus 
pneumonia, C. tetani, and C. novyi) (Smith and William, 1984; Bernheimer, 
1976). Theta toxin has been purified by anion-exchange and gel permeation 
chromatography (Yamakawa and Sato, 1977) and has a molecular size of 51 
KDa by polyacrylamide gel electrophoretic analysis. This estimate agrees 
with amino acid analysis. Theta-toxin, activated by cysteine, is lethal for 
mice (i.v. injection), and the lethality is reportedly due to the cardio 
depressant effect of toxin-induced release of  endogenous mediators such as 
platelet-activating factor (Stevens et al., 1988). 
 Tweten (1988) recently has cloned and expressed the gene for theta-
toxin in E. coli. The gene product was identical to the theta-toxin produced 
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by the donor strain in amino-terminal sequence and in sodium dodecyl 
sulfate-gel electrophoretic analysis. Both had an estimated molecular mass 
of 54 KDa and were of comparable hemolytic activity. The 1.8-kb 
chromosomal fragment generated a peptide of 499 amino acids that included 
a 27-residue signal peptide. The secreted form of the theta-toxin has a 
calculated molecular weight of 52, 469. It has 42% homology with 
streptolysin 0 and 42% with pneumolysin. All three hemolysins share an 
identical region of 12 amino acid residues that include the single cysteine 
residue of the molecule, which is involved in the thiol activation. 
1.2.3.2.3. Neuraminidase: 
 Neuraminidase, or siolidase, serves many microorganisms as a 
pathogenicity factor in a variety of ways (Mueller, 1976). 
 Its action on erythrocytes may render them panagglutinable, resulting 
in increase of blood viscosity and promoting capillary thrombosis. Its 
modification of ganglio sites on host cell surfaces may allow more direct 
contact of pathogens with the host, or it can provide suitable receptors for 
other toxins produced by the same or other microorganisms. (Hathway, 
1990). 
1.2.4. Antimicrobial susceptibility:  
 In vitro studies of the susceptibility of C. perfringens to 
chemotherapeutic agents are numerous. Penicillin is known to be 
particularly active against C. perfringens. Resistance to penicillin is very 
rare and B. lactamase has not been demonstrated in C. perfringens. 
tetracycline resistance is the most common antibiotic resistance trait found 
in C. perfringens (Lyras and Rood, 1996). It has been reported that C. 
perfringens can carry the tetracycline-resistance genes tet A (P), tet B (P), tet 
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A 408(P), tet M and tet Q (Kather, Marks and Foley, 2006; Lyras and Rood, 
1996; Martel et al., 2004; Sasaki et al., 2001). 
 Resistance to chloramphenicol in C. perfringens is not common, 
though several resistant isolates have been identified (Bannam and Rood, 
1991). No resistance to the ionophorous anticoccidial (IAC) narasin, an 
important substance used to control clostridiosis in the Nordic countries, has 
been found (Martel et al., 2004; Watkins et al., 1997). 
1.2.5. Toxinotyping of C. perfringens: 
 Detection of C. perfringens toxin types and subtypes is critical for a 
better understanding of the epidemiology of C. perfringens infections and 
may be helpful in the development of effective preventive measures. (Baums 
et al., 2004). 
 The typing of C. perfringens strains was originally established based 
on neutralization of the pathological effect of each major toxin, both trypsin 
treated and untreated, with appropriate antisera in laboratory animal models 
(Sterene and Batty, 1975). This toxino-typing requires a continuous supply 
of laboratory animals and the use of monovalent diagnostic sera which are 
increasingly difficult to find and are extremely expensive. Moreover, the 
result of the toxin-typing can not be obtained until 24 or even 48h of 
observation have elapsed. (Kadra et al., 1999). In diagnostic laboratories this 
differentiation has been replaced by rapid and easy to use enzyme linked 
immunosorbent assays (ELISA). (Nagahama et al., 1991). Although the 
ELISA allows reliable typing of C. perfringens isolates, the options for 
subtyping are limited. For example, so far no ELISA is available to detect 
the B2-toxin. In addition high levels of enterotoxin have been shown to be 
present during sporulation only (Czeczulin et al., 1993). As a consequence 
sporulation of C. perfringens isolates has to be induced via specific 
 16
cultivation methods to detect enterotoxin producing strains (Duncan and 
Strong, 1986).  
 These problems have been solved by genotype C. perfringens isolates. 
Various PCR protocols including multiplex PCR assays had been 
established to genotype C. perfringens isolates  with respect to the genes 
cpa, cpb, etx, iap, cpe and cpb2, encoding  the α-, B-, ε, I, entero – and B2-
toxin, respectively (Daube et al., 1994; Songer and Meer, 1996 and Songer, 
1997; Yoo et al., 1997; Kanakaraj et al., 1998). 
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Table (2)  
  Diseases produced by toxigenic types of C. perfringens: 
(Data taken from Maclennan, 1962; Mqller et al., 1963 and Nillo, 1993). 
Toxin 
type 
Major 
toxin(s) 
Diseases 
A α Myonecrosis, food poisoning, necrotic 
enteritis in fowl, enterotoxemia in cattle and 
lambs, necrotizing enterocolitis in piglets; 
possibly equine colitis, canine hemorrhagic 
gastroenteritis 
B α , B, ε Dysentery in newborn lambs, chronic enteritis 
in older lambs (pine), hemorrhagic enteritis in 
neonatal calves and foals, hemorrhagic 
enterotoxemia in adult sheep  
C α , B Enteritis necroticans(pigbel) in humans; 
necrotic enteritis in fowl; hemorrhagic or 
necrotic enterotoxemia in neonatal pigs, 
lambs,calves, goats, foals; acute 
enterotoxemia (struck) in adult sheep.   
D  α, ε Enterotoxemia in lambs (Pulpy kidney) and 
calves, enterocolitis in neonatal and adult 
goats, possibly enterotoxemia in adult cattle 
E α,i Enterotoxemia likely in calves and lambs, 
enteritis in rabbits; host range and disease 
type unclear  
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A-E Enterotoxin Canine and porcine enteritis 
 
   1.2.6. Types of C. perfringens: 
 Classification of C. perfringens into one of the five toxin types A-E is 
based on the production of the major toxins α , B, ε, and I (Petit et al., 
1999), each type carries a different combination of the toxin gene (Khaldi et 
al., 2004). 
 In 1931, Wilsdon established four toxin types, A, B.C. and D, of C. 
perfringens by preparing toxin culture filtrates and their corresponding 
antitoxin sera and observing the differential mouse protection by the sera. 
Wilsdon found that type A antiserum neutralized only type A cultures, type 
B neutralized all four types, type C neutralized all but type D, and type D 
neutralized filtrates contained multiple antigens. These antigens were later 
designated as alpha, present in all four types, beta present in types B and C, 
and epsilon, present in types B and D. (Sterne and Warrack, 1964). A fifth 
type (type E) was established by Bosworth in 1943 when he isolated a strain 
from a calf that produced a lethal toxin that could not be neutralized by type 
A, B, C, or D antitoxin or any combination. Type E antitoxin neutralized 
type A toxin filtrates as well as those of the homologous strain but not those 
of type B, C, or D. Bosworth proposed that the unique lethal factor in type E 
cultures be designated as iota. Type F had been established for a strain 
isolated from an outbreak of human necrotic enteritis in Germany (Zeissler 
and Rassfeld, 1949). 
  The organisms produced alpha-and beta-toxins and would have been 
classified as type C on that basis, but was unusually heat resistant and lacked 
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three minor antigens (delta, theta, and kapa) found with the classic type C 
strains (Sterne and Warrack, 1964).. 
 This distinction was subsequently deemed unjustified because 
discrepancies in ancillary characteristics among other strains were noted, 
and establishing new types to denote such differences would become 
unmanageable (Sterne and Warrack, 1964). 
1.2.6.1. Type A: 
 Strains of type A are ubiquitous, are the most common toxinotype in 
the environment (Petit et al., 1999), being found in most soils that are 
specifically cultured for C. perfringens (Smith and Williams, 1984). Well 
known as cause of wound contamination, anaerobic cellulites, and gas 
gangrene (Hatheway, 1990), strains of type A also cause enteric disease. 
Enterotoxemia in lambs, known as yellow lamb disease, occurs primarily in 
spring in California and Oregon, when the population of nursing lambs is 
high (McGowan et al., 1958 and Fleming, 1985). 
 Affected animals exhibit depression, anemia, icterus, and 
hemoglobinuria, dying after a clinical course of 6 to 12 h (Russell, 1970). 
Type A strains have been isolated frequently in the western United States 
from calves with tympany, abomastitis, and abomasal ulceration. Gross 
lesions include hemorrhage and ulceration of the abomasal mucosa. Severe 
diarrhea may occur in calves, but enteric lesions can be obscured by rapid 
autolysis. Gram-positive bacilli are often found on the mucosa and in the 
submucosa (Daube et al., 1994 and Roeder et al., 1988). 
 Necrotic enteritis, a disease of domestic chickens worldwides is 
usually caused by C. perfringens type A (Al-Sheikhly and Truscott, 1977) or 
type C (Mullaney et al., 1984).  
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 Intestinal clostridiosis in adult horses occurs as profuse watery 
diarrhea with high mortality, and large numbers of type A organisms are 
demonstrable in the gut (Princewill and Oakley, 1976; Wierup, 1977). 
 Type A has been linked to enteric disease in suckling and feeder pigs 
with mild necrotizing enterocolitis and villous atrophy (Popoff and Jestin, 
1985; Johannsen et al., 1993). Other reports of enteric disease associated 
with C. perfringens type A include enterotoxemia in minks (macarie et al., 
1980), muskrats (Vustina, 1988), and racing camels (Seifent et al., 1992), 
gastroenteritis in black-footed ferrets (Schulman, 1993) and acute toxemia in 
water buffaloes (Worrall et al., 1987). 
1.2.6.2. Type B: 
 C. perfringens type B is the etiologic agent of dysentery in newborn 
lambs. Disease occurs primarily in the border country between England and 
Scotland, as well as in Wales, South Africa, and the Middle East (Timoney 
et al., 1988). 
 A similar disease was reported in Montana (Tunnicliff, 1933) 
although isolates of type B are relatively rare in North America. Lamb 
dysentery usually develops during the first few days of life, although older 
lambs may be involved as an outbreak progress (Dalling,1926). After the 
infection is acquired from the dam or the environment, organisms in the gut 
increase in numbers, especially with heavy lactation by the dam. The result 
is enterotoxemia accompanied by enteritis and extensive hemorrhage and 
ulceration of the small intestine (Frank, 1956 and Roberts, 1958). The 
primary sign is sudden death, without forewarning in peracute cases. In 
acute incidents, cessation of feeding and severe abdominal pain are 
accompanied by bloody diarrhea, with recumbency, coma, and death less 
than 24 h after on set.  Incidence is often as high as 30%, with case fatality 
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rates approaching 100%. Chronic disease (Called pine) in older lambs 
manifests as chronic abdominal pain without diarrhea. Type B may also be 
associated with hemorrhagic enteritis in goats, calves and foals (Frank, 1956 
and Roberts, 1958). There has been little experimental study of the 
pathogenesis of infections by type B (Jansen, 1961). 
1.2.6.3. Type C: 
 Infections by C. perfringens type C have been reported in pigs, cattle, 
sheep, horses, chickens, humans, and dogs in the united states, Denmark, 
Great Britain, Japan, and elsewhere (Mackinnon, 1989). Newborn animals 
are typically most susceptible, perhaps because of ready colonization of the 
gut by C. perfringens in the absence of well established normal intestinal 
flora. Alteration of the flora by sudden dietary changes may also be an 
inciting factor in type C infections (Timoney et al., 1988). 
 Piglets are perhaps more commonly affected by type C than are other 
domestic animals (Fitzgerald et al., 1988; Johnson et al., 1992). 
Type C is the most commonly reported clostridial enteric pathogen of foals 
in North America (Dickie et al., 1978; Drolet et al., 1990; Howard-Martin et 
al., 1986). Clinical signs include depression, severe hemorrhagic diarrhea, 
dehydration, and occasionally colic (Howard-Martin et al., 1986). 
 At least one type C isolate has been obtained from peracute to acute, 
lethal, hemorrhagic enteritis in dogs (Argenti et al., 1987; Lage et al., 1992). 
Untyped isolates, associated with a similar but milder necrotic process, were 
also obtained from a high proportion of dogs with a primary parvovirus 
infection (Turk et al., 1992). 
1.2.6.4. Type D: 
 Type D strains cause enterotoxemia, also known as sudden death or 
overeating, in sheep of all ages except newborns (Timoney et al., 1988). 
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 It is probably most prevalent in lambs 3 to 10 weeks old, often 
suckling heavily lactating ewes grazed on luxuriant pastures. Enterotoxemia 
is also a predominant cause of death in weaned animals up to 10 months of 
age, usually those fed rich rations of grain in feedlots. Disease is often 
associated with upsets in the gut flora, such as result from sudden changes to 
a rich diet or from continuous feeding of high levels of feed concentrates 
(Popoff, 1984). Appropriate microenvironments lead to rapid multiplication 
of type D and production of toxin, almost certainly favored by the presence 
of excess dietary starch in the small intestine (Bullen, 1970). A high 
concentration of toxin facilitates its absorption (Nillo, 1993). 
 Pulpy kidney, another common name for type D enterotoxemia, is 
derived from one of the hallmark lesions in affected sheep, a result of 
postmortem autolysis, which occurs rapidly in hyperemic, toxin damaged 
tissue (Songer, 1996). Type D enterotoxemia is also important in calves 
(Griner et al., 1956; Munday et al., 1973), in goats (Oxer, 1956), and rarely 
in adult cattle (Mumford, 1961), deer, domesticated camels, and horses 
(Carrol  et al., 1987). 
 Enterotoxemia in suckling calves is similar to the disease in sheep 
(Griner et al., 1956; Lulov and Angelov, 1986). In neonatal and adult goats, 
however, catarrhal, fibrinous, or hemorrhagic enterocolitis is a consistent 
lesion (Blackwell and Butler, 1992; Blackwell et al., 1991), and the classic 
pulpy kidney is absent. Small amounts of toxin detected in the gut of normal 
animals are considered innocuous, but persistence of high concentrations of 
toxin leads to an increase in permeability and to absorption of toxin into the 
circulation (Bullen, 1970). A primary target of toxin is the central nervous 
system, where it produces foci of liquefy active necrosis, perivascular 
edema, and hemorrhage, especially in the meanings (Buxton et al., 1978). 
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The extent of clinical signs of central nervous system derangement, 
including in coordination and convulsions, is directly related to the severity 
of lesions (Griner, 1961). Hemorrhage is not a hall mark of typical type D 
induced disease in sheep or cattle, although hemorrhagic areas in the small 
intestine and petechial hemorrhages of the endocardium can be present, as 
can subendacardial hemorrhage around the mitral valve (Jubb et al., 1993). 
Disease in goats is present frequently as hemorrhagic enterocolitis, which 
can be chronic, it is often associated with lactation and high food intake. The 
basis for this species to species difference in clinical picture is unknown 
(Blackwell et al., 1991). Peritoneal and pericardial effusions are typical in 
sheep (Jubb et al., 1993). Hyperglycemia and glycosuria are 
pathognomoncic for type D enterotoxemia (Gardner, 1973; Nillo, 1993). 
These events apparently occur very rapidly, probably in the first hour after 
toxin enters the circulation (Songer, 1996). 
1.2.6.5. Type E: 
 Type E is an apparently uncommon cause of enterotoxemia of lambs, 
calves, and rabbits (Baskerville et al., 1980). I enterotoxemia in a calf and 
lambs was reported 50 years ago in Britain, but it is uncertain if published 
accounts since that time of hemorrhagic, necrotic enteritis of calves in 
Australia (Hart and Hooper, 1967) and of detection of the organism and I 
toxin in ovine or bovine intestines postmortem in the absence of signs of 
clostridial enterotoxemia (Sterne and Thomson, 1963) represent genuine 
cases. Recent experimental work demonstrated the ADP-ribosylating nature 
of I toxin, and characterization of the genes will provide a further basis for 
study of this toxin’s role in the pathogenesis of intestinal infections. The 
functional similarity of C. perfringens I toxin to the toxin of C. spiroforme 
suggests that infection by the latter may be mistaken for infection by the 
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former and vice versa if detection of toxin in the gut is the sole diagnostic 
measure. Further experimental work is needed to clarify the role of each of 
these organisms as etiologic agents of disease in domestic animals (Songer, 
1996). 
 
1.2.7. Economical significance: 
 Loveland and Kaldhusdal (2001) studied the association between 
Clostridium perfringens infection and production performance in broiler 
flocks during a 2.5 years time period when clinical and subclinical necrotic 
enteritis was frequently seen. They found that the farmer’s  profit on average 
was reduced by 33% when comparing flocks with high and low levels of the 
disease. Impaired feed conversion, reduced live weight at slaughter and 
increased condemnation percentage were major causes of production losses 
associated with Clostridium perfringens infection. Subclinical clostridial 
enteritis has also been associated with impaired feed conversion and retarded 
growth in a pen trial (Kaldhusdal and Hofshagen, 1992). 
1.2.8. C. perfringens food borne illness: 
 The earliest report of food-borne illness outbreaks due to C. 
perfringens was provided by McClung in 1945. In four episodes, patients 
experienced nausea, intestinal cramps, and a pronounced diarrhea 8 to 12 h 
after consuming chicken dishes prepared on one day and served the 
following day samples of the foods showed heavy contamination with 
Gram-positive rods, which were identified as C. perfringens (Hatheway, 
1990). 
 Hobbs et al., 1953 observed similar outbreaks in England; the 
causative organisms were of toxin type A. They noted that the spores of 
implicated strains were considerably more heat resistant and the organisms 
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were less hemolytic than the classic strains. Outbreak stains in the United 
States were usually more like the classic strains, with spore death within 10 
min at 100°C, rather than spore resistance to 100°C for more than 1 h as 
observed with the British Strains. Sutton and Hobbs, 1965 later found that 
both heat-susceptible and heat-resistant strains were implicated in England. 
Symptoms of the illness occurred in human volunteers after ingestion of a 
large number of viable vegetative bacteria (more than 5X108), but not after 
ingestion of spores or cell-free culture fluid (Diche and Eleck, 1957; 
Hauschild and Thatcher, 1967). 
 An enterotoxin released from the cells during sporulation was 
responsible for the diarrheal illness (Duncan and Strong, 1969., Duncan et 
al., 1972). It has been generally assumed that enterotoxin is a byproduct of 
sporulation, perhaps a spore coat protein, but synthesis of substantial 
amounts of enterotoxin by nonsporulating cultures has been demonstrated 
convincingly (Goldner et al., 1986). 
 C. perfringens food borne illness undoubtedly occurs frequently, but 
because of the mildness of the disease it is often not reported. Between 1970 
and 1980, 567 outbreaks of food borne illness due to C. perfringens were 
confirmed in England (Stringer, 1985). In the United States, about 25 
outbreaks are reported each year (Hatheway et al., 1980). 
1.2.7. Clostridium Perfringens diseases in Poultry: 
 Clostridial infections associated with four disease conditions in 
poultry or game birds, clostridium colinum is the cause of ulcerative 
enteritis, C. perfringens and C. septicum have been isolated from cases of 
necrotic enteritis or gangrenous dermatitis, and C. botulinum is the 
etiological agents of botulism (Barnes, 2003). 
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 C. perfringens also is being increasingly recognized as a cause of 
cholangio hepatitis in chickens (Kaldhusdal et al., 2001), and it has been 
associated with cellulites involving the tail of turkeys (Carr et al., 1996) and 
gizzard erosions in neonatal chicks (Jordan, 1996).Possible vertical 
transmission of C. perfringens has been shown (Shane et al., 1984). 
 
1.3. Necrotic enteritis: 
 The etiologic agent of NE is Clostridium. perfringens types A and C 
(David, 1998). It was first recorded by Bennetts (1930) in Australia, and 
fully characterized by Parish (1961a, b, c) in the United Kingdom. 
Interestingly, NE did not appear in a 1964 guide to common poultry diseases 
in the UK (British Oil and Cake Mills, 1964), nor in 1979 global disease 
survey (Biggs, 1982). Even as recently as 1997, it did not meet special 
attention in an international poultry disease directory (Van der Sluis, 1997). 
Soon afterwards however, NE emerged as a worldwide problem (Van der 
Sluis, 2000a b, Van Immerseel et al., 2004). 
 Furthermore,the occurrence of the causative agent of NE, Clostridium 
perfringens, in poultry meat is an important threat to public health (Van 
Immerseel et al., 2004). 
1.3.1. Host: 
 Necrotic enteritis has been reported in many bird species. Among 
chickens the disease is by far most common in broilers, but outbreaks in 
layer pullets and adult layer strain chickens have also been reported. 
(Kaldhusdal, 2002). 
1.3.2. Predisposing factors: 
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 Clostridium perfringens is a common inhabitant of the chicken gut 
and its presence does not lead to disease without the presence of 
predisposing factors (Gholamiandekhordi et al., 2006). 
 Coccidial infections are assumed to be a predisposing factor in many 
cases. These organisms invade and damage intact mucosal gut tissue, which 
is likely to favour the establishment of a non-invasive bacterium like 
Clostridium perfringens (Kaldhusdal, 2002). 
 Also concurrent coccidio infection has been shown experimentally to 
predispose to the disease (Shanel et al., 1985). 
 At the molecular level, one or several factors triggering the alpha 
toxin production of Clostridium perfringens may be essential. One the 
bacteria produce significant amount of toxins, these toxins eventually induce 
gut tissue necrosis, favouring proliferation of Clostridium perfringens and 
further tissue damage within the mucosa. (Kaldhusdal, 2002). 
 Diet is believed to be an important determinant of the disease. 
Manipulation of the diet can affect the numbers of C. perfringens in the 
intestional tract (Buranton et al., 1997). High levels of wheat and barley 
have been associated with NE in experimental and epidemiological studies 
(Branton et al., 1987; Ridded et al., 1992; Kaldhusdal et al., 1992; 
Kaldhusdal et al., 1996). Also diets rich in fish meat predispose to necrotic 
enteritis (Kocher, 2003) Feed and litter contaminated with clostridial spores 
have been incriminated as source of infection. (Wicker et al., 1977 and 
Ficken et al., 1977) and litter high in fiber content has been associated with 
necrotic enteritis (Truscott et al., 1977). 
 The viscosity of the intestinal contents will affect clostridial 
proliferation in the proximal intestinal tract, and the inclusion of enzymes to 
 28
off set the viscosity of wheat and barley is an important control factor (Smit, 
1996). 
1.3.3. Clinical signs and lesions: 
 The prominent feature of necrotic enteritis is acute death, with 
mortality rates that can reach 50% (Riddell and Kong, 1992). 
 Clinical signs in naturally occurring outbreaks include marked to 
severe depression, decreased appetite, reluctance to move, diarrhea and 
ruffled feathers. (Bains, 1978; Helmboldt and Bryant 1971). Most evident 
macroscopical lesions can be seen in the small intestine, but lesions can also 
be detected in other organs, such as the caeca, liver and kidney. The 
duodenum, jejunum and ileum and some times also the caeca, are thin 
walled, friable, dilated and filled with gas (Broussard et al., 1986). Mucosal 
surfaces are covered with a grey brown to yellow-green diphteric membrane 
or pseudomembrane (Gadzinski and Julian, 1992). 
 Microscopic changes in natural outbreaks are characterized primarily 
by severe necrosis of the intestinal mucosa with an abundance of clinical 
signs fibrin admixed with cellular debris adherent to the necrotic mucosa 
(Nairn and Bamford, 1967., Helmboldt and Bryant, 1971., Long et al., 
1974,). Initial lesions develop at the apices of villi and are characterized by 
slouphing of epithelium and colonization of exposed lamina proria with 
bacilli, accompanied by coagulation necrosis. Areas of necrosis are 
surrounded by heterophils. Progression of lesions usually occurs from villi 
apices to crypts. Necrosis may extend into the submucosa and muscular 
layers of the intestine. Numerous large bacilli often are observed attached to 
cellular debris. In birds that survive, regenerative changes consist of crypt 
epithelial cell proliferation with a corresponding increase in mitotic figures. 
Epithelid cells are primarily cuboidal, with a relative decrease in goblet and 
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columnar epithelial cells. Villi are relatively short and flat. In many 
outbreaks various sexual and a sexual stages of coccidia are also found in the 
intestine (Hemboldt and Bryant, 1971, Long et al., 1974, Nairn and 
Bamford, 1967). 
 
1.3.4. Diagnosis: 
 Diagnosis of NE can be made based on typical gross and microscopic 
lesions and isolation of the causative agent. In field cases of N.E., C. 
perfringens can be isolated readily from intestinal contents, the scraping of 
intestinal wall, or hemorrhagic lymphoid nodules by anaerobic incubation 
overnight at 37°C on blood agar plates (Fickon and Berkhoff, 1989). 
Identification of C. perfringens can be done. Some commercially available 
media may not be formulated adequately to selective cultivation and 
enumeration of C. perfringens unless used in combination with other tests 
for specific identification (Dafwang et al., 1987). 
 Diseases that must be differentiated from NE are ulcerative enteritis 
(UE) and Eimeria brunette infection. Ulcerative enteritis is caused by C. 
colinum; characteristic gross lesions are multiple areas of necrosis and 
ulceration in the distal small intestine and ceca and areas of necrosis in the 
liver. Lesions of NE usually are confined to jejunum and ileum with little or 
no involvement of ceca or liver. These distinguishing characteristics  should 
allow differentiation of NE and UE. Isolation and identification the causative 
agent will confirm the diagnosis (Wages and Opengart, 2003). 
1.3.5. Treatment: 
 In field cases the disease normally responds well in 24 to 48 hours to 
oral treatment with one of a variety of antibiotics (long, 1973).  Several 
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workers have reported the results of in vitro sensitivity tests on C. 
perfringens isolates with rare exception (Narin and Bamford, 1967). 
 Smith 1972 dosed day old chicks orally with C. perfringens isolates 
from cases of necrotic enteritis and conducted in vivo sensitivity tests. He 
found that a number of antimicrobial agents when added to the ration 
decreased the clostridial count in the feces of birds after they consumed the 
medicated feed from one day. 
 In some areas at the present time, an antibiotic is added to the feed of 
broiler chickens for the first month of life to prevent necrotic enteritis (Long, 
1973). 
1.3.6. Control: 
 The use of most antimicrobial growth promoters leads to a dramatic 
decrease in the incidence of necrotic enteritis in poultry, relative to non-
medicated animals (Van Immersal et al., 2004). Necrotic enteritis in 
different mammalian species including humans can be prevented by 
vaccination (Lawrence et al., 1990), also vaccination against coccidiosis 
may indirectly prevent losses from clostridium (Williams, 2002). 
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Chapter Tow  
Materials and Methods 
 
2.1. Sterilization: 
2.1.1. Hot-air oven (160°C for one hour) 
 Used for sterilization of glassware like Petri dishes, pipettes, tubes, 
flasks and glass-rods. These were sterilized in the hot-air oven at 160°C for 
one hour. 
2.1.2. Autoclaving: (121°C – 1516 square inch) 
 Media, solutions, screw capped bottles, rubber-stoppered flasks were 
sterilized by autoclaving at 121°C for 15 minutes and 110°C for 5 minutes 
for sugar media. 
2.1.3. Irradiation and disinfectants: 
 Used for aseptic work, addition of supplements and pouring plates. 
Phenolic disinfectants and absolute alcohol were used for disinfecting floors 
and stage of a U.V room followed by U.V irradiation for 20 minutes. 
2.2 Collection of blood: 
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 Blood for enrichment of media was collected by veni-puncture of the 
Jugular Vein of a healthy donor sheep. It was defibrinated by shaking the 
sterile flask containing glass beads. 
 The flask was transferred to the laboratory where the defibrinated 
blood was aseptically distributed in 20ml aliquots into sterile McCartne,ys 
bottles. 
 
 
 
2.3. Reagents and media additives: 
2.3.1. Distilled water (D.W) 
 Tap water was distilled using distiller. 
2.3.2. Normal saline: 
 Normal saline was prepared according to CruichShank, (1975). 
 Ingredients:  
 Sodium chloride (NaCl)   8.5g 
 D.W.      1000ml 
 The sodium chloride was dissolved in distilled water, the solution was 
distributed in bottles of different sizes and autoclaved at 121°C for 15 
minutes and stored at 4°C. 
2.3.3. Staining reagents: 
2.3.3.1. Crystal violet 
 Crystal violet   1.0g 
 D.W.     100.0ml 
2.3.3.2. Lugol’s iodine 
 Iodine    1.0g 
 Potassium iodide   2.0g 
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 D.W.     100.0ml 
2.3.3.3. Carbol fuchsin: 
 A. Basic fucshin   1.0g 
          Absolute ethanol  10.0ml 
 B. Phenol    5.0g 
           D.W.    100.0ml 
        Mixed A and B 
 
 
2.4. Reagent in PCR: 
2.4.1. Saturated bromophenol blue: 
 Bromophenol blue   10% 
 Bromophenol blue   5 g 
 D.W.     50ml 
2.4.2. Ethidium bromide solution: 
 10mg/ml used to visualize DNA 
 Ethidium bromide    0.2g 
 D.W.      20.0ml 
Mixed well and stored at 4°C in the dark (Brown or foil covered bottles). 
It was handled with gloves and was avoided inhalation. 
2.4.3. Gel loading buffer used to load DNA samples in gels: 
 Glycerol     5.00ml 
 TBE (5x)     250.00ml 
 Saturated bromophenol blue  1.00 ml 
 Xylene cyanol (10% suspension) 1.00ml 
 D.W.      2.75ml 
 Divided to 1ml aliquots and stored at -20°C.  
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2.4.4. TBE buffer (Tris base Boric Edta): 
 Boric acid     14g 
 Edta      0.93g 
 Tris base     27.5g 
 D.W.      250ml 
  The buffer was adjusted to pH. 8.3 
 
 
 
2.4.5. Preparation of running buffer: 
 TBE (5x)     1ml 
 D.W.      300ml 
2.4.6. TE buffer (tris/EDTA) 
 Tris 10mM pH 7.4    0.5ml of 2M stock 
 0.1mM EDTA, pH 8   20µl of 0.SM stock H2O 
to make    99.3ml 
 Total      100.0ml 
  It was stored at room temperature. 
2.4.7. Agarose gel: 
 1.5% agarose containing 5mg/ml ethidium bromide 
 Agarose    0.75g 
 TBE     50.00ml 
 The mixture was melted in a microwave oven, cooled, 2.5µl of 
ethidium bromide was added to final dilution of 5µg/ml, swirled and poured 
in loading chamber. The comb (gel cutter) was placed and the gel was left to 
solidify for 15 minutes. 
2.5. Preparation of media: 
 35
2.5.1. Blood agar medium: 
 Forty grams of (Oxoid CM55) blood agar base were suspended in a 
litre of distilled water the pH was adjusted to 7.4. It was then sterilized by 
autoclaving at 121°C for 15 minutes. After cooling to about 46°C, 
defibrinated sheep blood was added aseptically in 7-10 concentration before 
pouring plates. 
2.5.2. Shahidi and Ferguson Perfringens Agar (S.F.P.A) 
 This media was prepared as described by Shahidi and Ferguson 
(1971).  
One litre of SFP agar contained: 
Tryptose (Difco)                                                                       15g Yeast 
extract (Difco)                                                                                   5g 
Ferric ammonium citrate                                                                   1g 
 Sodium metabisufite (Na2S2O2)                                                       1g 
 Polymyxin B sulfate (Antimicrobic vial P, Difco)                       30,000 units 
 Kanamycin sulfate                                                                         0.012g 
 Agar                                                                                                 20g 
 Water                                                                                               900ml 
      Egg yolk emulsion was dissolved in water. After thorough mixing, the 
pH was adjusted to 7.6. The basal medium was autoclaved in 900ml portions 
at 121°C for 10 min. After cooling to about 50°C, 100ml of the 50% egg 
yolk emulsion was added to each 900ml of the basal medium thoroughly 
mixed, and added aseptically in 10-20ml amounts to Petri dishes. The 
medium was allowed to solidify, incubated overnight at 35C, and examined 
the following day for dryness and sterility.  
2.5.3. Egg Yolk emulsion: 
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 Fresh eggs were washed thoroughly with soap and tap water, scrubbed 
several times with ethyl alcohol and left to dry in clean metal tray. The eggs 
shell was opened and the egg white was aseptically discarded. The eggs 
Yolk were then collected aseptically into sterile beaker. An equal volume of 
sterile normal saline was added to the egg yolk, mixed with shaking or 
stirring with sterile glass-rod. The egg yolk emulsion was then distributed in 
sterile 100ml bottles and kept at 20°C for further use. 
 
 
 
2.5.4. Egg yolk medium: 
 All ingredients with exception of egg yolk emulsion were dissolved in 
water. After thorough mixing the pH was adjusted to 7.6. The medium was 
autoclaved at 121°C for15 minutes. The medium was then cooled to about 
50°C and 100ml of 50% egg Yolk in normal saline was added, thoroughly 
mixed and aseptically dispensed in 10 to 12ml amounts into sterile Petri 
dishes. The medium was allowed to solidify, incubated overnight at 37°C 
and examined for dryness and sterility on the following day.  
2.5.5. Lactose motility agar: 
      Lactose motility agar was prepared with tryptose, 15g; yeast extract, 10g, 
lactose, 10g; sodium phosphate (dibasic), 5g; phenol red, 0.05g; agar, 3g; 
and distilled water, 1,000ml. The ingredients were dissolved in the water, the 
pH was adjusted to 7.5, and the lactose and phenol red were added. Ten 
milliliters of the medium was dispensed into tubes. The cotton plugged tubes 
containing the medium were autoclaved at 118°C for 15 min. 
 Before use, the medium was boiled for 10 min and coded 
immediately. 
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2.5.6. Reinforced Clostridial medium (RCM) 
 Thirty-eight grams of RCM (Oxoid,CM149) was suspended in 1 litre 
of distilled water (DW), and heated in a water bath then sterilized by 
autoclaving at 121°C for 15 minutes. 
2.5.7. Cooked meat media: 
 Ten grams of granules of cooked meat medium (Oxoid, CM82) was 
transferred into McCartney bottles and 10ml of DW was added. The medium 
was then autoclaved at 121°C for 15 minutes for sterilization. 
 
 
2.5.8. Hugh and Leifson’s (O.F) medium: 
 Peptone, 2g; NaCl, 5g; K2HPO4; 0.3g; agar, 3g; and distilled water 
1000ml, bromothymol blue 0.25% aqueous solution 15ml, steamed to 
dissolve, the pH was adjusted to 7.1. Indicator was added to the medium 
which was then sterilized by autoclaving at 115°C for 20 minutes. Ten ml of 
sterile glucose solution was aseptically added to 90ml of the medium to give 
a final concentration of 1%. It was then distributed into test tubes each 
contained 10ml. 
2.5.9. Peptone water 
 Fifteen grams of dehydrated (Oxoid CM9) peptone water were 
rehydrated in a litre of distilled water, mixed well. The pH was adjusted to 
7.2 and then autoclaved at 121°C for15 minutes. 
2.6. Collection of samples: 
 Three hundred and forty intestines were collected, one 140 from field 
cases which were brought to the department of Avian Pathology and 
Diagnosis (C.V.R.L.) for investigation, and the remaining 200 from abattoirs 
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in (Khartoum north) Bahry . All intestinal samples had lesions of necrotic 
enteritis. 
 Sixty cloacal swabs were taken from chickens with avian influenza 
and had diarrhea. 
2.7. Isolation Procedure: 
 Under aseptic conditions, the intestines were opened with sterile 
blades, parts of the intestinal mucosa were scraped with a wire loop and 
cultured into reinforced clostridial medium, also cloacal swabs were 
cultivated in the same medium. 
 Inoculated RCM were heated at 80°C for 10 minutes to destroy 
vegetative organisms followed by anaerobic incubation using anaerobic jar,s 
with gas bag generating kits at 37°C for 24-48 hours. After that subcultures 
were made on blood agar plates for 24-48 hours, then cultures were 
examined with the naked eye for growth, colonial morphology and 
haemolysis. Smears were made from colonies surrounded by double zones 
of haemolysis, and stained with Gram stain. After purification of isolates 
biochemical tests were done to identify the bacteria. 
2.8. Preservation of the cultures: 
 Pure, full identified colonies were inoculated on cooked-meat medium 
and then incubated at 37°C for 24-48 hours and then stored at 4°C in 
refrigerator. 
2.9. Staining Technique 
2.9.1. Preparation of smears: 
 Smears were prepared by emulsifying a small part of the colony in a 
drop of normal saline and the suspensions were spreaded on a clean slide. 
The smears were allowed to dry in air and then fixed by gentle flaming. 
2.9.2. Gram’s stain: 
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 The prepared slides were placed on the rack and flooded with crystal 
violet-stain for one minute. The slide was left covered with iodine for one 
minute, rinsed with water, acetone was poured for 15 seconds, and the slides 
were rinsed with water again. The slides were counter stained with carbol 
fuchsin for one minute, rinsed with water and Dried by blotting with filter 
paper. 
2.10. Biological and biochemical methods: 
2.10.1. Catalase test: 
 A small amount of culture was picked with the help of a sterile 
pasteur pipette placed on a clean grease-free slide then a drop of 3% aqueous 
solution of hydrogen peroxide was placed over the culture and observed for 
production of gas bubbles. 
2.10.2. Oxidase test (Kovacs, 1956) 
 One percent aqueous solution of tetramethyle-p-phenylene diamine 
dihydrochloride was used to soak strips of whatman No. 1 filter paper for 
about 30 seconds, after which the strips were oven dried till white bleaching. 
For use, a discrete colony was picked and rubbed over the surface of the 
strip, the development of purple colour was recorded as positive for 
cytochrome oxidase. 
2.10.3. Urease Test (Christensen’s, 1946): 
 A urea agar slant was streaked with the test culture and incubated at 
37°C for 24-48 hours. The development of a pink colour was indicative of 
production of NH3. Negative and weak tests were left for a week before 
discarded.  
2.10.4. Sugar fermentation: 
 This test was carried out on media containing Sucrose, Maltose, 
Mannitol, Lactose, Fructose, Salicin, Raffinose and Glucose.The 
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concentration of the sugar was 1% in peptone water. Each test culture was 
inoculated into a set of sugar tubes, incubated at 37°C and examined for acid 
or gas production for 14 days. When this occurred it was indicated by the 
colour change to pink, when no acid was produced the medium colour 
remained unchanged. 
2.10.5. Gelatin hydrolysis (or liquefaction) 
 Inoculated Nutrient gelatin was inoculated with a straight wire loop 
and incubated at 37°C for up to 14 days and observed every 2-3 days, then 
placed in a refrigerator for 2h and examined for liquefaction. 
  
2.10.6. Motility tests: 
2.10.6.1. Hanging drop test: 
 A loop full of liquid culture was transferred to a coverslips. The 
coverslips were put on glass slides with petroleum vasline and examined 
microscopically. 
2.10.6.2. Lactose fermentation and motility test: 
 Lactose fermentation and motility were both examined in lactose 
motility agar (LMA) medium as described by Shahidi and Fergusion (1971). 
The inoculum was stabbed deeply to one third of the depth in the medium 
which was heated and allowed to solidify just before use. Growth was 
observed after 24 hours under anaerobic incubation at 37°C. 
2.10.7. Lecithinase Production: 
 The isolated organisms were streaked on lactose milk egg-Yolk 
medium and incubated anaerobically overnight at 37°C. Positive reaction 
was indicated by the presence of opacity around the growing colonies. 
2.10.8. Half Plate neutralization test: 
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 Standard C. perfringens antiserum type A was spreaded to cover half 
of the egg-Yolk plate, titled and allowed to dry. Pure colonies of the isolates 
were streaked in the medium starting from the untreated half of the plate. 
The plates were then incubated anaerobically at 37°C for 24 hours. 
2.12. Multiplex PCR procedure: 
2.12.1. DNA Extraction: 
 Five to ten colonies of C. perfringens from blood agar plates 
suspended in 200ml eppendorf tube using micropipettes. The samples were 
boiled at 100°C for 20 minutes, snapped cooled on ice for 5 minutes and 
centrifuged at 13.000 revolutions per minute for 3 minutes. The supernatant 
was transferred to clean tubes and stored at -20°C. 
2.12.2. Oligonucleotides: 
 PCR primers of Qiagen, 1000 Atlantic A ve, suite 108, Alameda, 
CA94501, were kindly supplied by Dr. Zakia Abbass head department of 
Pathology in (C.V.R.L.). 
 The prepared master mix from Invitrogen Corporation, under U.S. 
patent Nos. 5, 338, 5, 587, 287 was kindly supplied by Dr. Dia El Din 
Ahmed Salih (Kassla Regional Research Lab). 
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Primers used: 
Type Sequence  5 – 3 
Amplican 
size 
C. perfringens A toxin 
forward CPa-1 
Reverse CPa-2 
GCTAATGTTACTGCCGTTGA 
 
CCTCTGATACATCGTGTAAG 
324 
C. perfringens-B toxin 
forward CPb-1 
Reverse CPb-2 
GCGAATATGCTGAATCATCTA 
 
GCAGGAACATTAGTATATCTTC 
196 
C. perfringens-E toxin 
forward eTX-1 
Reverse Etx-2 
GCGGTGATATCCATCTATTC 
 
CCACTTACTTGTCCTACTAAC 
655 
C. perfringens-I toxin 
forward Ia-1 
Reverse Ia-2 
ACTACTCTCAGACAAGACAG 
 
CTTTCCTTCTATTACTATACG 
446 
 43
C. perfringens-e toxin 
forward CPe-1 
Reverse CPb2-2 
GGAGATGGTTGGATATTAGG 
 
GGACCAGCAGTTGTAGATA 
233 
C. perfringens-B2 toxin 
forward CPb2-1 
Reverse CPb2-2 
AGATTTTAAATATGATCCTAAC 
 
CAATACCCTTCACCAAATACTC 
567 
   
 
2.12.3. PCR reaction: 
 Two trials were made for PCR the first one optimized in a total of 
40µl master mix consisting of 5.0µl of 10 X PCR buffer, 1.2µl of dNTPs, 
0.5µl of tag polymerase (5 units/µl), 1.0µl MgCl2, 26µl DDW and six 
primers 1.3µl for Ia, 1.2 for PCR, 1.1µl for etx, 0.9µl for cpb, cpe, cpb2. The 
master mix for all samples was mixed by vortexing and then pipetted in 5µl 
PCR  tubes 10µl of DNA was added for each PCR reaction. A negative 
control was included in which 10µl of DDW was added instead of DNA. 
 In the second trial a prepared master mix was used which consist of 
22 mMtris-HCl, 55mm KCL, 1.65mm MgCl2 220mmdGTP, 220mmdATP, 
220mmdTTP, 220mmdCTP and 22U/ml complexed recombinant tag DNA 
polymerase with platinum Tag Antibody. This master mix for 50µl reaction 
uses 45µl of PCR mastermix and 5µl of primer and DNA. 
 The PCR tubes were then placed in a Biometra DNA thermocycler the 
reaction was subjected to 35 cycles of amplification consisting of 2 minutes 
of initial denaturation at 94°C, followed by 1 minute of denaturation at 
94°C, 1 minute of annealing at 55°C prior to 1 minute of extension at 72°C. 
 The presence or absence of the desired band was resolved by running 
5ml of PCR product through 1.2% agarose gel stained with 2.5µl ethidium 
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bromide. Molecular sizes were determined based on a 100 pb ladder 
molecular mass marker. This was performed at 75V for 45 minutes and the 
analysis was done by using an automated photo documentation system (Bio. 
Doc. Analyza, digital). 
2.13. Drug sensitivity test: 
 This test was carried out essentially as described by Bauer, Kirby, 
Sherris and Truck (1966) and Benson 1980. The procedure followed, briefly 
known as Kirby-Bauer method, is reliable, accepted method in current use 
and sanctioned by the U.S. FDA and the subcommittee on Antimicrobial 
susceptibility testing of the National Committee for Clinical Laboratory 
Standards, NCCLS (Benson, 1980). 
 Three to ten colonies were picked from C. perfringens grown 
anaerobically on blood agar (Oxoid), subcltured into RCM (Oxoid) and 
incubated anaerobically at 37°C for 24 hrs. 
 For preparation of the bacterial suspension, the inoculated RCM was 
then diluted with RCM to a degree of turbidity visually equivalent to that of 
the standard prepared by adding 0.5ml of 1% BCL2 to 99.5ml of 1% H2SO4 
(O.36N). 
 The bacterial suspension was inoculated onto the top of the medium 
and spread by horizontal rotation on a surface. Excess bacterial suspension 
was aspirated by a sterile Pasteur pipette. Then the inoculum was allowed 3-
5 minutes to dry before the antimicrobial agent disks were placed on and 
gently pressed. Inoculated plates were incubated at 37°C overnight. 
 The diameter of the inhibition zone including that of the antimicrobial 
disk was measured. The inhibition zone produced by antimicrobial drug was 
compared with its corresponding standard zone of inhibition to determine 
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whether the specified C. perfringens isolate was sensitive or resistant to the 
drug. 
 
 
 
 
 
 
 
 
 
 
Chapter Three 
Results 
      In this study 40 isolates of C.perfringens were isolated from 400 
samples, 340 were intestinal specimens and 60 were cloacal swabs as shown 
in table (3). 
      One hundred and forty intestinal specimens were taken from field cases 
came to the department of Avian Pathology and Diagnosis for investigation 
as shown in table (4), the remaining twenty hundred from abattoirs in 
Khartoum North (Bahry). Intestinal specimens had lesions of necrotic 
enteritis fig (1). 
 Cloacal swabs were from cases of avian influenza as shown in table (5). 
Table (3) 
Source and numbers of specimens. 
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Source of 
specimens 
Organs 
examined 
No.of 
specimens 
No.positive % 
Field cases Intestine 140 16 11.42 
Cases of avian 
influenza 
Cloacal swabs 60 10 16.66 
Abattoir Intestines 200 14 7 
 
 
 
 
 
 
 
 
Table (4) 
   Clostridium perfringens isolated from field cases 
  
Sample     
no. 
   
Types of 
chicken 
     
Flock status 
  
Genotype of 
isolate 
 
1 Layer Tape worms  +  ND   A(CPe+)         
2 Layer ND  A(CPe+)          
3 Layer ND    A(CPe+)       
4 Layer Marek,s A(CPe+) 
5 Layer Marek,s A(CPe+) 
6 Layer Marek,s A(CPe+) 
7 Layer Coccidia A(CPe+) 
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8 Layer Coccidia A(CPe+) 
9 Broiler Gumboro + Coccidia A(CPe+) 
10 Layer Tape worms A(CPe+) 
11 Layer Coccidia A(CPe+) 
12 Layer Unknown A(CPe+) 
13 Layer Coccidia A(CPe+) 
14 Layer Coccidia A(CPe+) 
15 Layer Unknown A(CPe+) 
16 Layer Unknown A(CPe+) 
 
 
 
 
Table (5) 
   Clostridium. perfringens isolated from cases of Avian influenza (cloacal 
swabs) 
Sample no. Type of chicken Clinical Signs Genotype of 
isolate 
1 Layer Yellowish 
diarrhea 
A(CPe+) 
2 Broiler Diarrhea A(CPe+) 
3 Layer whitish diarrhea A(CPe+) 
4 Layer whitish diarrhea A(CPe+) 
5 Layer whitish diarrhea A(CPe+) 
6 Layer Diarrhea A(CPe+) 
7 Layer Diarrhea A(CPe+) 
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8 Layer Diarrhea A(CPe+) 
9 Layer Diarrhea A(CPe+) 
10 Layer Diarrhea A(CPe+)  
 
 
 
 
 
 
 
 
 
 
3.1Characteristics of isolates: 
3.1.1Colonial morphology: 
   The organisms produced circular colonies about 2mm. Large, with 
glistening or finely granular surfaces with entire edges. Some strains 
developed dull and granular colonies with radial surfaces and dentated 
edges. 
3.1.2 Gram, s stain: 
  All (1oo %) isolates were Gram-positive rod when freshly examined. Old 
cultures possessed less affinity to retaining the crystal violet (fig 2). 
3.1.3 Catalase test: 
 All (1oo %) isolates of C.perfringens were catalase negative. 
3.1.4 Motility test: 
 All (1oo %) isolates were non motile by both hanging drop and L.M agar 
tests. 
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3.1.5 Haemolysis test: 
All (1oo %) isolates were haemolytic for sheep blood cells. They developed 
double zone of haemolysis, colonies were surrounded by inner zone of 
complete haemolysis and wide zone of incomplete haemolysis (fig 3). 
3.1.6 Growth in RCM: 
  All (1oo %) isolates propagated in RCM with production of turbidity and 
gas (fig 4). 
3.1.7Growth in SFP medium: 
On SFP All (1oo %) isolates developed black colonies, 2-4 mm in diameter 
encircled by distinct zone of opalescence indicating the production of the 
enzyme    lecithinase. 
 
 
3.1.8Growth on blood agar: 
  All (100%) isolates developed colonies on sheep blood agar with different 
shapes and sizes. 
3.1.9Growth in cooked meat medium: 
All (1oo %) produced turbidity and gas. 
3.1.10Aerobic growth: 
None of the isolates grew on blood agar when incubated aerobically at 37c0 
for 24 hours. 
3.1.11Anaerobic growth: 
  All (1oo %) isolates grew on blood agar under anaerobic conditions. 
3.1.12 Lactose fermentation: 
    All (1oo %) isolates changed the colour of LM agar from red to yellow 
and produced gas due to lactose fermentation (fig5). 
3.1.13 Naglar, s reaction: 
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All (1oo %) isolates caused opalescence of egg yolk agar and Shahidi and 
Ferguson perfringens agar (fig 6). 
3.1.14 Naglar,s half-plate antitoxin: 
Inhibition of lecithinase production by C.perfringens type A antitoxin was 
noted by C.perfringens, some isolates showed complete inhibition and others 
incomplete inhibition. 
3.1.15 Gelatin test: 
  All (1oo %) isolates liquefied the gelatin. 
 
 
 
 
 
3.2 Result of PCR: 
       All 40 isolates of C.perfringens were analysed using multiplex PCR. 
Alpha toxin gene cpa and enterotoxin gene were observed in agarose gel as 
bands at approximately 324bp and 233bp respectively, as shawn in Fig (7). 
       This result showed that all isolate C.perfringens belonged to toxin type 
A and were enterotoxin +ve (CPe+ typeA). No bands were seen for iota-
epsilon-beta-and beta2 toxin genes. 
3.3 Results of sensitivity tests 
         The concentration of antimicrobial drugs used, and standard zones of 
inhibition produced by susceptible, intermediate, and resistant Clostridium 
perfringens isolates are shown in table (6). The diameter of growth 
inhibition zones including those of the drug disks were measured and are 
shown in Table (7). 
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Thirty of forty isolates were tested for their susceptibility to different anti 
microbial agents. All isolates were sensitive to ampicillin and furazolidone 
and resistant to gentamycin and kanamycin. Ninety percent of isolates(90%) 
were susceptibile to penicillin while, 80% to cloxacillin, 73% to bacitracin 
70% erythromycin, and 50% lincomycin  (Fig, 8, 9, 10, 11 and 12 
respectively).  
      Fig.13 showed the susceptibility of C.perfringens to 9 antimicrobial 
drugs.  
     Fifteen different patterns of drug sensitivity test were obtained (sensitive, 
intermediate and resistant) of 30 C.perfringens isolates to nine antimicrobial 
drugs as shown in Table (8). 
 
 
 
 
 
 
Table (6) 
Antimicrobial agents used, Concentrations and the standard zones of 
growth inhibition of resistant intermediate and susceptible Clostridium 
perfringens. 
 
Name of 
Antimicrobial 
Conc.  Standard zones of growth inhibition 
in mm 
  Resistant Intermediate Susceptible 
Ampicillin 10mcg ‹  12 12-13     › 13 
Bacitracin 10units ‹  9 9-12     ›12 
Penicillin 10units ‹  12 12-21    ›  21 
Erythromycin 30mcg ‹  14 14-17    › 17 
Furazolidone 100mcg ‹  15 15-16    ›16 
Cloxacillin 5mcg ‹  12 12-13    ›13 
Lincomycin 10mcg ‹  17 17-20    ›20 
Gentamycin 30mcg ‹  13 13-14    ›14 
Kanamycin Mcg ‹  14 14-17    › 17 
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*adopted from NCCLS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (7)  
The diameter (mm) of grwoth inhibition zones of nine antimicrobial 
agents. 
 
Isolate 
no. 
Amp Bac Pen Ery Fur Clo Lin Gen Kan 
1 22 19 22 18 20 16 13 0 0
2 23 0 30 20 22 11 11 10 7
3 23 18 28 18 22 17 20 0 0
4 22 17 25 17 18 17 20 0 0
5 21 7 32 0 20 17 13 7 0
6 18 0 30 18 25 10 15 0 6
7 23 21 32 20 22 19 20 0 0
8 20 9 33 19 16 20 13 0 0
9 23 18 33 18 20 15 21 0 0
10 22 7 28 0 21 20 22 10 8
11 20 20 32 25 23 15 23 13 0
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12 25 18 30 20 18 20 22 0 0
13 21 20 33 29 35 0 20 10 0
14 26 17 30 22 27 23 17 0 0
15 23 19 33 20 22 20 11 10 10
16 20 22 30 21 23 12 25 13 0
17 23 21 32 21 23 18 25 0 0
18 20 20 30 19 23 20 20 0 0
19 24 20 30 21 22 20 13 0 0
20 22 11 30 0 21 20 0 10 7
21 25 20 22 16 23 17 15 0 0
22 20 15 21 15 17 15 13 0 0
23 20 15 20 18 21 11 13 0 0
24 26 10 28 20 18 22 23 13 10
25 20 0 23 0 23 15 15 11 10
26 20 17 23 19 17 20 20 0 0
27 22 17 23 18 21 17 20 0 0
28 20 16 20 17 22 15 20 0 0
29 20 10 25 0 18 20 16 11 8
30 20 15 20 15 17 11 13 0 0
 
Table (8)  
Sensitivity patterns of C.perfringens isolate 
 
Sensitivity pattern 
 
No. of 
isolates 
Percentage
Sensitive to all 9 antibiotics except gentamycin and 
Kanamycin  
10 33.3%
Sensitive to ampicillin,penicillin,furazolidone,and 
cloxacillin and resistant to the lincomycin,gentamycin 
and a kanamycin. 
2 6.7%
Resistant to gentamycin and kanamycin, intermediately 
resistant to bacitracin and sensitive to ampicillin, 
penicillin, erythromycin,furazolidone and cloxacillin and 
lincomycin. 
1 3.3%
Sensitive to ampicillin, ,furazolidone, 
lincomycin,bacitracin , erythromycin ,cloxacillin, and  
intermediately resistant to penicillin and fully resistant to 
gentamycin and kanamycin. 
1 3.3%
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resistant to gentamycin and kanamycin, intermediately 
resistant to cloxacillin and sensitive to ampicillin, 
penicillin, erythromycin,furazolidone, bacitracin and 
lincomycin. 
1 3.3%
Sensitive to ampicillin, bacitracin and furazolidone, and 
intermediately resistant to penicillin and erythromycin, 
resistant to cloxacillin, lincomycin, gentamycin and 
kanamycin. 
1 3.3%
Sensitive to ampicillin, penicillin, 
erythromycin,furazolidone, bacitracin and cloxacillin and 
resistant to lincomycin, gentamycin and kanamycin. 
3 10.0%
Sensitive to ampicillin, penicillin,furazolidone, bacitracin 
, erythromycin and cloxacillin, and  intermediately 
resistant for lincomycin and resistant to gentamycin and 
kanamycin. 
1 3.3%
Sensitive to ampicillin, penicillin,furazolidone, 
,cloxacillin and lincomycin and resistant to 
erythromycin, bacitracin,gentamycin and kanamycin. 
1 3.3%
Sensitive to ampicillin, penicillin,furazolidone and 
cloxacillin and intermediate  for bacitracin, resistant to 
erythromycin, ,  lincomycin, gentamycin  kanamycin. 
2 6.7%
 
 
Sensitive to ampicillin, penicillin,furazolidone, bacitracin, 
cloxacillin and intermediately resistant to erythromycin and 
resistant to  lincomycin, gentamycin and kanamycin 
2 6.7% 
Sensitive to ampicillin, penicillin,furazolidone, erythromycin 
and cloxacillin and intermediately resistant to bacitracin, 
resistant to  lincomycin, gentamycin and kanamycin 
1 3.3%
Sensitive to ampicillin, penicillin,furazolidone and 
erythromycin, resistant to cloxacillin ,bacitracin,  lincomycin, 
gentamycin  and kanamycin. 
2 6.7%
Sensitive to ampicillin,furazolidone, erythromycin and 
bacitracin,intermediately resistant to penicillin resistant to 
cloxacillin ,  lincomycin, gentamycin and kanamycin. 
1 3.3%
Sensitive to ampicillin, penicillin,furazolidone, 
bacitracin,erythromycin and lincomycin and resistant to 
cloxacillin ,  gentamycin and kanamycin 
1 3.3%
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Fig .1. Chicken affected with necrotic enteritis. 
The intestines were hemorrhagic with gases. 
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Fig.2. Gram stain of a smear from colonies of C.perfringens. 
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Fig.3. Growth of C.perfringens on blood agar,shawing doube zones of 
haemolysis . 
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 Fig.4. Growth of C.perfringens in RCM medium with turbidity  and gas 
production 
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                 Fig.5. Lactose fermentation by C.perfringens 
              and change of colour from red to yellow. 
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          Fig.6. Growth of C.perfringens on egg yolk medium 
           shawing Lecithinase production (opacity).  
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                                1          2          3        4          5         6          7        8 
    
 Fig.7. Agarose gel-electrophoresis of the PCR products obtained from 
amplification of cpa (324 bp) and cpe (233bp) of different C.perfringens 
isolates. Lane 1: 100bp ladder; lane 2: negative control; lanes3-8: 
C.perfringens isolates. 
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              Fig.8. Sensitivity of C. perfringens to penicillin 
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         Fig.9. Sensitivity of C. perfringens to cloxacillin 
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      Fig.10. Sensitivity of C.  Perfringens to erythromycin 
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          Fig.11. Sensitivity of C.  Perfringens to bacitracin. 
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         Fig.12. Sensitivity of C. perfringens to lincomycin. 
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Fig.13. Sensitivity of C. perfringens to different antimicrobials agents. 
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Chapter four  
Discussion 
 
        In this study 40 isolates of C.perfringens were recoverd from 400 
samples (10%). Intestinal specimens were taken from cases showing lesions 
of necrotic enteritis. Olumbunmi and Taylor (1985) stated that cultures of 
lesion material could frequently yield heavy growth of C.perfringens. 
     In severe cases, lesions are longitudinally expanded along the gut; the 
epithelium is eroded and detached. Gram- positive rods occur in the lesions, 
(Nairn and Bamford, 1967;Kaldhusdal and Hofshagen, 1992). Gardiner 
(1967) and Bains (1968) mentioned that C. perfringens was considered to be 
the only bacterium of significance isolated from lesions of necrotic enteritis 
or seen in smears from intestinal lesions.  
     Cloacal swabs were taken from chickens suffering from avian influenza 
and the obvious clinical signs were diarrhoea.This is in agreement with 
Helmboldt and Bryant (1971) who reported that diarrhoea might be 
associated with acute necrotic enteritis. 
      In the present work, C.perfringens was isolated from both broilers and 
layers of different ages. Craven et al. (2001) stated that the disease occurred 
most commonly in broiler chicks but was also observed in older pullets and 
layers also Ficken and Wages, (1997) mentioned that C.perfringens could be 
isolated in chickens of all ages. 
      One or several predisposing factors may be required to elicit the clinical 
signs and lesions of necrotic enteritis. Gut damage caused by coccidial 
infection some times predisposes birds to clostridial infection and necrotic 
enteritis (Hermans and Morgan, 2003), also Van immerseel et al. (2004) 
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mentioned that coccidial infection stimulated proliferation of intestinal 
C.perfringens.  
      In the field, coccidial pathogens are mostly found associated outbreaks 
of necrotic enteritis (Broussard et al., 1986). It is documented in numerous 
studies that coccidial vaccines and coccidiostatic drugs are able to prevent 
C.perfringens associated necrotic enteritis (Williams et al., 2003) and 
removal of coccidiostat from poultry feed is considered as a predisposing 
factor for the development of necrotic enteritis (Elwinger et al., 1992).The 
finding of this study confirmed the above mentioned statement.Six isolates 
were found positive for coccidiosis beside necrotic enteritis. 
     Also low immunity due to infection with viral diseases predisposes 
chickens to necrotic enteritis. In this study one isolate of C.perfringens was 
from chickens suffered from Gumboro, 3 isolates were from chickens with 
Marek,s disease and 10 isolates were from cases of avian influenza.This 
results is in accordance with the finding of Schuring and Van Gils (2001) 
who stated that exposure to infectious bursal disease, chicken infectious 
anemia virus and Marek,s disease as well as non specific stress, may 
predispose birds to necrotic enteritis. 
     The composition of feed may greatly influence the occurrence of necrotic 
enteritis in chickens. Different reports showed that maize in chicken feed 
reduces the incidence and severity of necrotic enteritis, as opposed to diets 
based on wheat, rye and barley (Branton et al., 1987; Kaldhusdal and 
Hofshagen, 1992; Riddel and Kong,1992). When broiler chickens were feed 
C.perfringens in different feeds for 3 consecutive days, mortality ranged 
from 0.0 to 12.5% in broilers fed a maize-based diet, while the mortality in 
animals fed a diet with high amounts of wheat, rye or barley ranged from 
26% to 35% (Riddell and Kong,1992). 
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     High protein content in poultry feed seems to increase the incidence of 
necrotic entritis. An increased risk of necrotic enteritis is often associated 
with animal protein ingredients such as fishmeal or meat and bone meal 
(Kocher,2003). Studies of the effects of vegetable protein ingredients, such 
as soy protein, on the incidence of necrotic enteritis in vivo are lacking (Van 
Immereel et  al., 2004). 
   In this study it can be concluded that all isolates of C.perfringens found in 
the intestines carried only the cpa gene and cpe gene, judging from the 
multiplex PCR, showing that all belonged to toxin type A and this is in 
agreement with the finding of other authors who established that all 
C.perfringes isolates from chickens to be type A (Hofshagen and Stenwig, 
1992., Songer, 1996., Yoo et al., 1997). Engstrom et al. (2003) mentioned 
that in poultry, almost exclusively C.perfringens type A has been isolated, as 
shown in studies in Scandinavia.  Van Immerseel et al. (2004) stated that 
toxinotypes B, D and E do not play a role in poultry diseases. 
The presence of of the beta2 toxin in C.perfringens isolates has been linked 
with increased incidence of bovine enterotoxaemia (Manteca et al., 2002), 
intestinal disorders in horses (Herholz et al., 1999), and diarrhea in piglets 
(Klaasen et al., 1999) and sheep (Garmory et al., 2000). In all these studies, 
a significantly higher incidence of beta2 toxin positive isolates was detected 
in animals having intestinal disease. This seems to be in contrast with 
C.perfringens isolates from poultry. In a study by Engstrom et al. (2003) 
0nly one C.perfringens PFGE types harboured the beta2 toxin. 
     Clostridium perfringens type A bacteria produces the alpha toxin (Tit 
ball, 1993). Kana Karaj (1998) stated that cpa was present in all the strains 
of C.perfringens, making it useful as a target for DNA- based assays to 
detect the organism. The α-toxin produced by C.perfringens is considered 
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to be the major virulence factor in the pathogenesis of necrotic enteritis. 
(AL-Sheikhly and Truscott, 1977), and it is by far the most potent in poultry 
(Kohler, 2002). 
  Alpha toxin from C.perfringens was the first bacterial protein shown to 
possess both enzymatic and toxic properties, it is a phospholipase C and 
exhibits hemolytic, necrotic vascular permeabilization, and platelet 
aggregating properties (Justin et al., 2002). 
        Some C.perfringens strains form additional toxins that have been 
proposed to be important for the pathogenesis of intestinal disorders (Baums 
et al., 2004). Some type A strains produce enterotoxin (CPE) which causes 
diarrhoea in humans and, most likely in various domestic animals (McClane, 
1996., Songer, 1996., Sarker et al., 1999) a result which substantiated by this 
work. Also McClane et al., 1988 mentioned that CPE production is most 
often reported in strains of type A, but it can be produced by all of the toxin 
types of C.perfringens. 
              The CPE appears to be a bifunctional toxin, which first induces 
cellular damage via its cytotoxic activity, resulting from plasma membrane 
permeability alterations caused by formation of CPE – containing complex 
that may corresponds to a pore. CPE then interacts with structural 
components of the epithelial tight junction, including certain claudins and 
occludin.These interaction can affect tight junction structure and function, 
there by altering paracellular permeability (Singh et al .,2000, 2001, 
McClane, 2000, 2001).    
         
         Craven et al., (1999) illustrated that enterotoxigenic strains of 
C.perfringens have been isolated from outbreaks of necrotic enteritis in 
chickens and enterotoxin could be detected in the jejunum of experimentally 
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infected chickens, however, the superficial lesions in the mucosa of jejunum 
caused by enterotoxin might favour growth of C.perfringens and production 
of  α-toxin (Engstrom et al., 2003).  
 When a nested PCR reaction was used after enrichment culture of intestinal 
contents of poultry, Miwa et al. (1997) found 40% of all tested intestinal 
contents samples were positive for the cpe gene, whereas 100% of 
C.perfringens isolates were positive in this study. 
The results obtained above disagree with Tschirdewahn et al. (1992) who 
stated that most isolates of C.perfringens from animals do not carry the 
enterotoxin gene and he mentioned that in a study of the presence of 
enterotoxigenic strains of C.perfringens in faeces of various animals, only 
10% of C.perfringens isolated from poultry carried the enterotoxin gene.  
  The genotype of cpa (alpha toxin or phospholipase C) with cpe 
(Clostridium perfringens enterotoxin) is generally associated with human 
food-borne disease strains. Human disease – associated food isolates of 
C.perfringens generally have a chromosomally located cpe gene, while the 
cpe locus of non – food borne isolates is episomally or plasmid located 
(Sparks et al., 2001). 
     Clostridium perfringens is one of the most frequently isolated bacterial 
pathogens in food borne disease outbreaks in humans, after some other 
pathogens such as Camplyobacter and Salmonella (Buzby and Roberts, 
1997).  
    Outbreaks due to C. perfringens can be traced back to different sources, 
one of which is poultry (Schiemann, 1977., Regan et al. 1995., Hook et al., 
1996). 
         Miwa et al., (1997, 1998) stated that chicken, porcine and bovine 
intestinal samples and meat were analyzed for the presence of CPE positive 
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strains. The amount of CPE positive samples in both the intestinal contents 
and meat of chickens was higher than for cattle and pig samples.    
      In this study we tried to get a broad idea on the susceptibility of C. 
perfringens to different antimicrobial agents vis: ampicillin, penicillin, 
furazolidone, cloxacillin, bacitracin, erythromycin, lincomycin, gentamycin 
and kanamycin. 
         Clostridium perfringens was higly susceptible to ampicillin and 
furazolidone (100%), followed by penicillin (90%), cloxacillin (80%), 
erythromycin (73%), bacitracin (70%) and the lower susceptibility was 
recorded for lincomycin (50%). 
        All isolates of C. perfringens were resistant to Kanamycin and 
Gentamycin. Rodriguez et al. (1980) who tested The sensitivity of E. coli, 
Staph.aureus and C. perfringens to various drugs under different conditions 
(including different culture media and incubation atmospheres) found that 
Gentamicin and kanamycin showed no activity in tests with brain heart 
infusion agar incubated anaerobically or in 10% CO2.  
         Experimentally, in vivo, a number of antimicrobial agents placed in the 
feed reduced the numbers of C. perfringens shed in the feces (Stutz et al., 
1983). These include virginiamycine, tylosin, penicillin, ampicillin, 
bacitracin, and furazolidone (Watkins et al., 1981). Outbreaks of necrotic 
enteritis can be treated effectively by administration of lincomycin (Humdy 
et al., 1983), bacitracin (Prescott et al., 1971) or Penicillin (Long and 
Trescott, 1976). 
    Long (1973) mentioned that enterotoxemia caused by C.perfringens 
responded readily to antibiotics such as penicillin or bacitracin to which 
virtually all isolates of C.perfringens were susceptible in vitro. Also Rood et 
al. (1978) studied the effect of penicillin on C.perfringens isolates obtained 
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from different animals and different sources. He found that penicillin was 
the most effective antibiotic against C.perfringens and recommended that 
penicillin should be used in the treatment of C.perfringens infections. 
     The study of Sasaki et al. (2001) and the present study suggest that 
C.perfringens had a low degree of resistance to ampicillin. 
     The result obtained in this work disagree with the finding of Heller and 
Smith (1973) who reported the resistance of C.perfringens to furazolidone, 
whereas in this study C.perfringens was highly susceptible (100%) to 
furazolidone.  
Martel et al. (2004) stated that all poultry isolates of C.perfringens in 1980 
were susceptible to erythromycin and this is in agreement with our finding 
,as in this study  73% susceptibility was obtained to erythromycin. But 
Smart, Truman and Stringer, (1983) found C.perfringens recovered from 
beef carcasses to be resistant to erythromycin. 
In Sudan Abdel Salam (1986) studied the sensitivity of 7 strains of 
C.perfringens from cases of necrotic enteritis, he found high susceptibility to 
bacitracin. 
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            Conclusion: 
1. We can conclude that DNA based techniques (PCR) have been 
developed for C.perfringens typing. Genotyping is reliable and 
practical and allows more accurate and complete determination of 
C.perfringens pathovars than doe’s classical toxinotyping. 
2. Bioassays may not be sensitive enough to detect the presence of 
enterotoxigenic strains in normal animals. The possible use of PCR 
for detection C.perfringens producing enterotoxin may, therefor, 
offer a considerable advantage over conventional techniques. 
3. The availability of a quick method to define exactly the toxin 
type of C. perfringens should shorten and simplify the development 
of adequate vaccines fitting the epidemiological situation. 
Recommendation:                                                                                                          
This study warrants further studies on the susceptibility of more    
strains of C. perfringens 
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